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Background: Evidence suggests that habitual snoring is an independent risk factor for poor glycemic health. We examined the 
associations between snoring with prediabetes and diabetes in Korean population.
Methods: Self-reported snoring characteristics were collected from 3,948 middle-aged adults without prior cardiovascular dis-
eases. Multivariable linear regression assessed the association of snoring intensity, frequency, disruptiveness, and disrupted 
breathing with fasting glucose and glycosylated hemoglobin (HbA1c) level. Then, multinomial regression evaluated how increas-
ing snoring symptoms are associated with the risk for prediabetes and diabetes, adjusting for socioeconomic and behavioral risk 
factors of diabetes, obesity, hypertension, and other sleep variables.
Results: Higher snoring intensity and frequency were positively associated with fasting glucose and HbA1c levels. Participants 
presenting the most severe snoring were at 1.84 times higher risk (95% confidence interval [CI], 1.09 to 2.29) for prediabetes and 
2.24 times higher risk (95% CI, 1.84 to 2.95) for diabetes, compared to non-snorers. Such graded association was also observed 
amongst the most frequent snorers with higher risk for prediabetes (odds ratio [OR], 1.78; 95% CI, 1.29 to 2.22) and diabetes (OR, 
2.03; 95% CI, 1.45 to 2.85). Disruptive snoring (OR, 1.60; 95% CI, 1.12 to 2.28) and near-daily disruptive breathing (OR, 2.18; 
95% CI, 1.02 to 4.19) were associated with higher odds for diabetes. Such findings remained robust after additional adjustment 
for sleep duration, excessive daytime sleepiness, unwakefulness, and sleep-deprived driving.
Conclusion: Snoring is associated with impaired glucose metabolism even in otherwise metabolically healthy adults. Habitual 
snorers may require lifestyle modifications and pharmacological treatment to improve glycemic profile.
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INTRODUCTION
A growing body of epidemiological evidence suggests that ha-
bitual snoring is an important risk factor for the development 
and exacerbation of cardiovascular and metabolic complica-
tions, including type 2 diabetes mellitus [1-3]. Considering 
that snoring is the most common and salient symptom of ob-
structive sleep apnea (OSA) [4], it is consistently associated 
with both high prevalence and incidence of type 2 diabetes 
mellitus among otherwise healthy adults [5]. Poor glycemic 
control amongst snorers prevails, even after accounting for 
other sleep-related conditions, such as extreme sleep duration, 
excessive daytime sleepiness, and chronic fatigue [6-11].
Considering that good sleep quality is essential to maintain 
normal physiological function to regulate normal somatic, 
cognitive, and psychological processes, it is important to ex-
amine the extent which snoring is associated with glycemic 
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adults 30 years or older, prevalence of prediabetes is 25.3% and 
14.4% for type 2 diabetes mellitus; their pervasiveness escalat-
ed drastically with older age [12]. Considering that both predi-
abetes and diabetes populations are at increased risk for micro-
vascular (chronic kidney disease, neuropathies, and retinopa-
thy) and cardiovascular diseases (CVD) [13], early detection 
and management of glycemic disorder are crucial. 
Whether various characteristics of snoring are associated 
with elevated risk of both prediabetes and type 2 diabetes mel-
litus is not well-established in the general population. More-
over, previous studies primarily utilized a single marker of 
sleep-disordered breathing rather than incorporating compre-
hensive aspects of sleep. Given the poor prognostics of uncon-
trolled glycemic state in regard to the CVD progression, inves-
tigating whether snoring can be indicative of adverse glycemic 
state may aid in identifying high-risk or already prevalent indi-
viduals for prediabetes and diabetes. In this context, the objec-
tive of this study is to examine the association of various char-
acteristics of snoring with prediabetes and type 2 diabetes mel-
litus, independent of other sleep characteristics among com-
munity-dwelling Korean adults. We hypothesized that individ-
uals presenting higher severity (louder sound and greater dis-
ruptiveness) and frequency of snoring will have positively 
graded risk for prediabetes and type 2 diabetes mellitus, com-
pared to non-snoring participants.
METHODS
Study population
The Cardiovascular and Metabolic Diseases Etiology Research 
Center (CMERC) Study has been approved by the Institutional 
Review Boards of Severance Hospital, Yonsei University Health 
System, Seoul, Korea (4-2013-0661). Written informed con-
sent has been obtained from all participants prior to the base-
line survey. Participants were ensured that they can withdraw 
from the study at any time, regardless of its cause, without any 
repercussions.
The study participants consisted of healthy community-
dwelling capital residents of Republic of Korea, between the 
age of 30 to 64 years, who were enrolled in the CMERC cohort. 
Briefly, the CMERC study aimed to identify novel risk factors 
and to investigate distribution and effects of known cardiac 
and metabolic diseases risk factors, ultimately to develop im-
proved CVD prediction tools for the general Korean popula-
tion [14]. Adhering to standardized protocols, trained re-
searchers collected detailed information on socioeconomic 
status, health behaviors, disease history, nutrition, and psycho-
social characteristics and performed blood and urine tests 
[14]. In the present study, among 4,060 participants who have 
undergone baseline examination at the CMERC center 1 be-
tween 2013 and 2018, participants either currently undergoing 
cancer treatment, diagnosed with heart failure or angina pec-
toris, or missing information on glycemic index were excluded, 
yielding 3,948 participants (1,800 male and 2,548 female) for 
the final analysis.
Assessment of exposure
A face-to-face interview obtained information on snoring and 
other sleep-related variables based on the Korean version of 
the Berlin Questionnaire [15]. Briefly, the Berlin Questionnaire 
is one of the most widely and readily used screening tools for 
OSA. In reference to polysomnography results, previous vali-
dation studies confirmed its sensitivity of 84.4% and specificity 
of 35.3% in both general population and sleep clinic patient-
based studies [16,17]. Another systematic review confirmed 
that among sleep clinic patients or self-reported habitual snor-
ers, the Berlin Questionnaire showed substantial OSA predict-
ability, with sensitivity and specificity as high as 81% and 80%, 
respectively [18,19]. Considering that in-laboratory polysom-
nography, currently the gold standard tool for OSA diagnosis, 
is infeasible for large-scale epidemiologic studies, Berlin Ques-
tionnaire collects sleep behavior in cost- and time-efficient 
manner. In this study, participants were inquired whether they 
are a habitual snorer. If affirmative, they were subsequently 
asked to rate their snoring frequency: never or rare, seldom (1 
to 2 time/month), sometimes (1 to 2 time/week), often (3 to 4 
time/week), or frequent (almost every night). The following 
question on sleep-disordered breathing (“Has anyone noticed 
that you quit breathing during your sleep?”) was evaluated in 
the same manner. The respondents rated the intensity of their 
snoring: slightly louder than breathing, as loud as talking, 
louder than talking, or very loud (can be heard in adjacent 
rooms). Lastly, participants were inquired whether own snor-
ing has bothered bed partners); the answer was dichotomized 
to either a “yes” or a “no.”
To simultaneously account for other various sleep-related 
factors, participants were additionally asked to report their 
weekday/workday sleep duration in exact hours and minutes, 
subsequently categorized into ≤5, 6, 7, 8, or ≥9 hours. Fre-
quency of unwakefulness (fatigue after waking up), excessive 
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daytime sleepiness (feeling tired or fatigued during day/active 
time), and history of sleep-deprived driving were also inquired.
Based on the responses to the aforementioned questions, we 
identified five sleep variables: snoring (frequency/intensity/
disordered breathing/disruptiveness), sleep duration, unwake-
fulness, excessive daytime sleepiness, and sleep-deprived driv-
ing. Our primary analysis focused on various characteristics of 
snoring, accounting for other aforementioned sleep variables. 
Assessment of glycemic profile
Participants underwent blood test after overnight fasting for a 
minimum of 8 hours. Fasting plasma glucose levels were as-
sessed using colorimetry method (ADIVA1800 Auto Analyzer; 
Siemens medical Sol., Deerfield, IL, USA) and glycosylated he-
moglobin (HbA1c) was analyzed using high-performance liq-
uid chromatograph (Variant II Turbo Hemoglobin Testing 
System; Bio-Rad, Irvine, CA, USA).
Prediabetes was defined as a fasting glucose level between 
100 mg/dL and 125 mg/dL or HbA1c level between 5.7% and 
6.4%. Type 2 diabetes mellitus was defined as fasting glucose 
level ≥126 mg/dL, HbA1c ≥6.5%, a self-reported physician-
diagnosis, or current use of oral glucose-lowering drugs or in-
sulin injection. The CMERC study did not collect sufficient in-
formation (e.g., C-peptide levels) enough to identify every sub-
type previously diagnosed; however, the entailed information 
regarding history of autoimmune or other chronic diseases, 
thereby able enabled us to distinguish between type 2 diabetes 
mellitus and other types of diabetes, such as type 1 diabetes 
mellitus or maturity onset diabetes of the young.
Assessment of covariates
Demographics, health-related behaviors, and disease history 
were obtained via face-to-face interview. Household income 
was categorized into cohort-specific quartile. Longest held and 
current occupation were classified into white or blue collar or 
unemployed. Education level was categorized into four groups: 
elementary school or below, middle school, high school, or 
college/university. Physical activity was assessed by the Korean 
version of the International Physical Activity Questionnaire 
standard [20]. The total metabolic equivalent of task was then 
categorized into quartile. Alcohol consumption and cigarette 
smoking were divided into non-, previous-, and current drink-
er/smoker. Information on familial and personal morbidity 
history included the age at first diagnosis of common chronic 
diseases, such as hypertension, diabetes mellitus, and so on. 
Accordingly, participants presented prescription records en-
tailing previous and current treatment status, including types 
of oral hypoglycemic medications or insulin injection.
Height was measured to the nearest 0.1 cm using stadiome-
ters (DS-102; Jenix, Seoul, Korea), and weight was measured to 
the nearest 0.1 kg on a digital scale (DB-150; CAS, Seongnam, 
Korea). To minimize measurement variability, a zero-point ad-
justment was routinely conducted using a standard ruler (170 
cm) and weights (20, 40, and 60 kg). Body mass index (BMI) 
was calculated as a ratio of weight in kilograms to height in 
squared meters. We defined obesity as BMI ≥25 kg/m2 based 
on the Asia-Pacific classification from the World Health Orga-
nization guideline [21]. Blood pressure (BP) was consecutively 
measured using both single- and double-arm automated oscil-
lometric device (HEM-7080 and HEM-9000 AI; Omron 
Health, Matsusaka, Japan) at a single sitting; the mean of sec-
ond and third measurements was adopted for analysis. Hyper-
tension was defined as systolic BP ≥140 mm Hg, diastolic BP 
≥90 mm Hg, self-reported physician-diagnosis, or current use 
of antihypertensive medication.
Statistical analysis
We compared anthropometric, socioeconomic, lifestyle, and 
morbidity characteristics of the participants across healthy gly-
cemic (“normal”), prediabetes, and type 2 diabetes mellitus 
groups using one-way analysis of variance. Next, we employed 
multivariable linear regression model to assess the association 
between individual dimension of snoring and fasting glucose 
level and HbA1c concentration, separately. Then, to examine 
whether snoring and its subcomponents are associated with 
increased risk of prediabetes and type 2 diabetes mellitus, we 
employed multivariable multinomial logistic regression to 
compare associations among normal, prediabetes, and type 2 
diabetes mellitus groups. All results are presented in odds ratio 
(OR) and 95% confidence interval (95% CI).
We selected potential confounders based on a review of the 
literature and logical assessment of potential causal relation-
ships accounting for biological plausibility. In the first model, 
we adjusted for age and sex. In the second model, we addition-
ally adjusted for BMI, hypertension prevalence, and socioeco-
nomic status, including education level, household income, 
and longest held occupation. In the third model, we addition-
ally adjusted for well-known cardiovascular and metabolic be-
havioral risk factors, including current smoking and drinking 
status and physical activity. To account for residual confound-
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ing even after adjusting for BMI and hypertension prevalence, 
subgroup analyses were done by further stratifying by obesity 
and hypertension status. To further explore whether the effect 
of snoring was independent of other sleep conditions, we si-
multaneously adjusted for all sleep-related variables, including 
sleep duration, unwakefulness, excessive daytime sleepiness, 
and sleep-deprived driving.
Hosmer-Lemeshow goodness of fit for logistic regression 
ensured appropriateness of the model. All statistical tests were 
two-sided, and the statistical significance was set at a P value 
<0.05. All analyses were performed using SAS version 9.4 
(SAS Institute Inc., Cary, NC, USA).
RESULTS
Among 3,893 participants, 1,224 (31.4%) participants had pre-
diabetes and 355 participants (9.1%) had type 2 diabetes melli-
tus. Table 1 compares the general characteristics of the study 
population across normoglycemic, prediabetes, and type 2 dia-
betes mellitus groups. Compared to normoglycemia group, 
prediabetes and type 2 diabetes mellitus groups were older and 
higher proportion of male sex, current smoker, obesity, and 
hypertension. Furthermore, there were significant differences 
in education level, household income, and drinking history 
among the three groups. Participants with type 2 diabetes mel-
litus had the highest proportion of habitual snorer (76.5%), 
followed by prediabetes group (73.2%) and lastly, the normal 
group (59.9%).
Table 2 presents age- and sex-adjusted mean comparison of 
fasting glucose and HbA1c levels by level of each snoring char-
acteristics. Compared to their non-snoring counterpart, par-
ticipants who habitually snore had higher fasting glucose (92.5 
mg/dL vs. 88.2 mg/dL) and HbA1c (5.7% vs. 5.6%) levels. Both 
indices were incrementally higher with increasing snoring in-
tensity, frequency, disruptiveness, and disrupted breathing.
Table 3 illustrates results from the multivariable linear regres-
sion of individual snoring characteristics with fasting glucose 
and HbA1c level. For each sleep variable dimension, the esti-
mates are obtained in reference to the lowest categorical level; 
for instance, the analyses on snoring frequency are in reference 
to the “never or rare” category. In prediabetes group, higher 
snoring intensity (β=1.20 mg/dL, P=0.001), frequency (β=0.99 
mg/dL, P=0.008), and bothersome snoring (β=0.96 mg/dL, 
P=0.007) were positively associated with fasting glucose level. 
Similar direction and magnitude of association were observed 
in type 2 diabetes mellitus group. Likewise, regardless of glyce-
mic status, higher intensity, frequency, and disruption were also 
positively associated with HbA1c levels. Such trend remained 
robust after stratification by sex (Supplementary Table 1).
Table 4 presents results from the multinomial logistic model 
comparing the risk for prediabetes and type 2 diabetes mellitus 
across categories of each snoring dimension. All risk levels are 
in reference to non-snorers with normal glycemic profile. After 
adjusting for age, sex, and known risk factors of type 2 diabetes 
mellitus, participants with the most severe snoring were at 1.81 
times higher risk (95% CI, 1.07 to 2.33) for prediabetes and 
1.84 times higher risk (95% CI, 1.14 to 2.95) for type 2 diabetes 
mellitus. Such graded association was also noted across more 
frequent snoring among participants with prediabetes (OR, 
1.79; 95% CI, 1.33 to 2.24) and type 2 diabetes mellitus (OR, 
2.05; 95% CI, 1.48 to 2.83). Disruptive snoring was associated 
with 1.59 times higher risk for type 2 diabetes mellitus (95% 
CI, 1.10 to 2.25) only. Likewise, positively graded association 
with more frequent disrupted breathing was observed only for 
type 2 diabetes mellitus; those reporting near-daily disrupted 
breathing had 2.2 times higher odds for type 2 diabetes melli-
tus (95% CI, 1.06 to 4.30), compared to those with complacent 
breathing. As a supplementary analysis, we examined the asso-
ciation of each sleep variable with prediabetes and type 2 dia-
betes mellitus (Supplementary Table 2). To integrate compre-
hensive aspects of sleep, we additionally adjusted for these 
variables when assessing the odds for prediabetes and type 2 
diabetes mellitus (Table 4). Additional adjustments did not re-
verse the direction nor noticeably diminish the strength of as-
sociation.
In the first subgroup analysis stratified by obesity status, the 
association between snoring intensity and frequency with type 
2 diabetes mellitus remained significant in participants with 
BMI less than 25 kg/m2 (Supplementary Table 3). Non-obese 
participants reporting the highest intensity snoring had 1.54 
times higher odds (95% CI, 0.97 to 2.66) for prediabetes and 
1.83 times higher odds (95% CI, 1.24 to 2.43) for type 2 diabe-
tes mellitus, compared to normal weight, non-snorers. More-
over, regardless of obesity status, participants reporting higher 
frequency snoring were at incrementally higher risk for both 
prediabetes and type 2 diabetes mellitus. The second subgroup 
analysis stratified participants by hypertension prevalence 
(Supplementary Table 4). Similarly, participants without hy-
pertension were at higher risk for prediabetes and type 2 dia-
betes mellitus across more intense and frequent categories of 
Snoring and pre- and type 2 diabetes mellitus
691Diabetes Metab J 2020;44:687-698 https://e-dmj.org
Table 1. General characteristics of the study population (n=3,948)
Variable Normal (n=2,369) Prediabetes (n=1,224) Diabetes (n=355) P value
Age, yr 49.0±9.8 54.0±7.7 55.4±7.0 <0.001
MET-min/wk 2,747.5±3,619.2 2,888.9±3,702.7 2,769.7±3,229.7 0.531
Fasting glucose, mg/dL 84.8±6.8 94.3±10.1 129.3±41.0 <0.001
HbA1c, % 5.3±0.2 5.9±0.2 7.2±1.3 <0.001
Sex <0.001
  Male 797 (33.6) 432 (35.3) 171 (48.2)
  Female 1,572 (66.4) 792 (64.7) 184 (51.8)
Education level <0.001
  Elementary school 98 (4.1) 87 (7.1) 36 (10.1)
  Middle school 164 (6.9) 124 (10.1) 52 (14.7)
  High school 871 (36.8) 517 (42.2) 146 (41.1)
  College/University 1,235 (52.2) 496 (40.5) 121 (34.1)
Household income 0.020
  Low 579 (24.4) 276 (22.6) 111 (31.3)
  Middle-low 572 (24.2) 315 (25.7) 75 (21.1)
  Middle-high 574 (24.2) 297 (24.3) 92 (25.9)
  High 644 (27.2) 336 (27.5) 77 (21.7)
Occupation 0.012
  White collar 951 (40.1) 404 (33.0) 125 (35.2)
  Blue collar 650 (27.4) 399 (32.6) 122 (34.4)
  Unemployed 768 (32.4) 421 (34.4) 108 (30.4)
Cigarette smoking <0.001
  Non-smoker 1,651 (70.0) 844(69.0) 198 (55.8)
  Former smoker 385 (16.3) 229 (18.7) 86 (24.2)
  Current smoker 333 (14.1) 151 (12.3) 71 (20.0)
Alcohol consumption 0.020
  Non-drinker 489 (20.6) 308 (25.2) 77 (21.7)
  Former drinker 105 (4.4) 44 (3.6) 24 (6.8)
  Current drinker 1,775 (74.9) 872 (71.2) 254 (71.6)
Obese, BMI ≥25 kg/m2 <0.001
  No 1,741 (73.5) 724 (59.2) 150 (42.3)
  Yes 628 (26.5) 500 (40.9) 205 (57.8)
Hypertension <0.001
  No 1,911 (80.7) 837 (68.4) 183 (51.6)
  Yes 458 (19.3) 387 (31.6) 172 (48.5)
Habitual snoring <0.001
  No 1,020 (43.1) 371 (30.3) 86 (24.2)
  Yes 1,349 (56.9) 853 (69.7) 269 (75.8)
Values are presented as mean±standard deviation or number (%). P value was derived from the one-way variance of analysis (ANOVA) for 
multiple comparisons.
MET, metabolic equivalent of task; HbA1c, glycosylated hemoglobin; BMI, body mass index.
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snoring, but the experience of bothersome snoring nor dis-
rupted breathing did not yield any significant results.
DISCUSSION
In this community-dwelling cohort of middle-aged Korean 
adults, snoring frequency and intensity were significantly asso-
ciated with higher odds for both prediabetes and type 2 diabe-
tes mellitus, independent of socioeconomic, behavioral, and 
other sleep-related factors. Furthermore, snoring also showed 
continuous association with elevated glycemic biomarkers in 
among persons with type 2 diabetes mellitus. Therefore, in a 
primary prevention setting, persons experiencing habitual 
snoring or OSA may be at high-risk for current or future type 
2 diabetes mellitus, and timely screening for diabetes may be 
advisable in these individuals. Conversely, in patients already 
with type 2 diabetes mellitus, habitual snorers may be potential 
targets for lifestyle modifications or more aggressive clinical 
interventions to improve sleep quality and to optimize glyce-
mic control.
Our findings on the association between snoring and type 2 
diabetes mellitus are consistent with previous studies. Among 
large Chinese community studies, both occasional and habitu-
al snoring were significantly associated 1.4 times higher risk 
for impaired fasting glucose and 1.1 times higher risk for im-
paired glucose tolerance, even after adjusting for diabetes- and 
Table 2. The mean level of fasting glucose and HbA1c by characteristics of snoring (n=3,948)
Snoring characteristic Participants Fasting glucose, mg/dL P value HbA1c, % P value
Presence <0.001 <0.001
  No 1,477 (37.4) 88.2±12.0 5.6±0.6
  Yes 2,471 (62.6) 92.5±15.9 5.7±0.7
Intensity <0.001 <0.001
  Does not snore 1,477 (37.4) 88.2±12.0 5.6±0.6
  Slightly louder than breathing 1,091 (27.8) 90.7±14.4 5.7±0.7
  As loud as talking 766 (19.5) 93.7±17.1 5.8±0.8
  Louder than talking 376 (9.6) 94.0±15.9 5.7±0.6
  Very loud. 216 (5.5) 94.6±17.6 5.8±0.9
Frequency <0.001 <0.001
  Never or nearly never 1,582 (40.3) 90.9±14.5 5.6±0.5
  1–2 times a month 552 (14.1) 90.8±14.3 5.7±0.8
  1–2 times a week 762 (19.4) 92.2±15.7 5.7±0.8
  3–4 times a week 495 (12.6) 92.4±15.6 5.7±0.7
  Nearly every day 534 (13.6) 95.0±17.9 5.8±0.7
Disruptive to others <0.001 <0.001
  Does not snore 1,477 (37.4) 88.2±12.0 5.6±0.6
  No 1,806 (46.0) 92.2±15.8 5.7±0.7
  Yes 644 (16.4) 93.4±16.1 5.7±0.7
Disrupted breathing <0.001 <0.001
  Never or nearly never 3,690 (90.7) 91.1±18.4 5.6±0.7
  1–2 times a month 110 (2.8) 95.7±18.8 5.8±0.7
  1–2 times a week 124 (3.1) 98.8±23.3 5.8±0.9
  3–4 times a week 71 (1.8) 99.1±33.9 5.9±1.0
  Nearly every day 63 (1.6) 99.8±25.5 6.1±1.1
Values are presented as number (%) or mean±standard deviation. P value was derived from the one-way variance of analysis (ANOVA) for 
multiple comparisons.
HbA1c, glycosylated hemoglobin.
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sleep-related covariates [13]. The Cardiovascular Health Study 
also demonstrated that diverse symptoms of OSA, including 
daytime sleepiness and disruptive snoring, were associated 
with elevated fasting glucose level and lower insulin sensitivity 
[22]. In the Nurses’ Health Study, the multivariable-adjusted 
hazard ratio of developing type 2 diabetes mellitus was 1.41 
Table 3. Association of individual characteristics of snoring with fasting glucose and HbA1c (n=3,948)
Snoring characteristic
Model 1 Model 2 Model 3
β P value β P value β P value
Fasting glucose, mg/dL
  Normal glycemic profile
    Intensity 1.24 0.008 1.21 0.009 1.20 0.009
    Frequency 1.03 0.027 1.04 0.027 1.02 0.028
    Bothersome 0.71 0.001 0.66 0.004 0.63 0.009
    Disrupted breathing 0.34 0.132 0.32 0.173 0.32 0.173
  Prediabetes
    Intensity 1.26 0.001 1.19 0.001 1.20 0.001
    Frequency 1.03 <0.001 1.02 <0.001 0.99 0.008
    Bothersome 1.00 0.001 0.97 0.007 0.96 0.007
    Disrupted breathing 0.55 0.056 0.50 0.144 0.49 0.168
  Type 2 diabetes mellitus
    Intensity 1.04 <0.001 1.00 <0.001 0.93 0.016
    Frequency 1.09 <0.001 1.03 0.012 0.97 0.018
    Bothersome 1.04 0.019 1.02 0.025 1.00 0.027
    Disrupted breathing 0.58 0.200 0.57 0.221 0.56 0.241
HbA1c, %
  Normal glycemic profile
    Intensity 0.03 0.008 0.03 0.007 0.03 0.007
    Frequency 0.03 <0.001 0.02 <0.001 0.02 <0.001
    Bothersome 0.04 <0.001 0.03 0.009 0.03 0.009
    Disrupted breathing 0.02 0.008 0.01 0.157 0.01 0.148
  Prediabetes
    Intensity 0.04 <0.001 0.04 <0.001 0.04 <0.001
    Frequency 0.04 <0.001 0.04 <0.001 0.04 <0.001
    Bothersome 0.06 <0.001 0.06 <0.001 0.05 0.004
    Disrupted breathing 0.04 <0.001 0.04 <0.001 0.04 <0.001
  Type 2 diabetes mellitus
    Intensity 0.02 0.009 0.02 0.008 0.02 0.008
    Frequency  0.03 <0.001 0.02 0.004 0.02 0.006
    Bothersome 0.008 0.040 0.006 0.114 0.006 0.118
    Disrupted breathing 0.002 0.413 0.001 0.621 0.001 0.602
The estimates are in reference to the lowest ordinal category of each snoring characteristics. Model 1 is adjusted for age and sex. Model 2 is ad-
justed for age, sex, body mass index, hypertension prevalence, education level, household income, and occupation. Model 3 is adjusted for age, 
sex, body mass index, hypertension prevalence, education level, household income, occupation, cigarette smoking, alcohol consumption, and 
physical activity.
HbA1c, glycosylated hemoglobin.
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(95% CI, 1.22 to 1.63) for self-reported occasional snorers and 
2.03 (95% CI, 1.71 to 2.40) for habitual snorers [5,23]. In a Ko-
rean study, compared to non-snorers, habitual snorers showed 
analogous baseline fasting glucose and insulin levels, but later 
underwent more drastic increase over 1- and 2-hour oral glu-
cose tolerance test [24]. In another community-dwelling Kore-
an population, the homeostatic model assessment-insulin re-
sistance showed dose-response relationship across higher fre-
quency snoring gradient in female [25].
However, our study extends the previous findings in two im-
portant ways. Firstly, it examined multiple characteristics of 
snoring, rather than simply assessing its absence or presence. 
Secondly, it examined both stages of diabetes (prediabetes and 
type 2 diabetes mellitus), simultaneously adjusting for surro-
gate markers for sleep fragmentation, obstruction, recurrent 
arousals, etc.
The observed association between snoring and type 2 diabe-
tes mellitus is biologically plausible. Snoring is a form of ab-
normal breathing during sleep that inhibits good quality sleep 
via oxygen desaturation and upper airway obstruction [11]. 
This, resultant intermittent hypoxia leads to insulin resistance 
and disrupts glucose metabolism via several pathways. First, 
increased sleep fragmentation and frequent arousals trigger 
pro-inflammatory cascade by elevating interleukin-6, C-reac-
tive protein, and fibrinogen levels and lowering albumin levels, 
thereby systematically damaging glucose stability and beta-cell 
function [26]. Another proposed mechanism is that snoring 
activates sympathetic nervous system, resulting in catechol-
amine elevation and hypothalamic-pituitary-adrenal axis acti-
vation. This conjointment of elevated cortisol, formation of re-
active oxygen species, and increased oxidative stress alter sleep, 
thereby glucose metabolism [27-30]. Lastly, snoring may be 
manifestation of behavioral risk factors of type 2 diabetes mel-
litus, such as lack of physical activity. Physical inactivity is 
known to reciprocate circulating leptin and ghrelin levels that 
are responsible for increased appetite, thereby encourage high-
er caloric intake [31]. Excessive energy consumption coupled 
with reduced physical activity can disrupt food intake pattern 
and energy expenditure, accelerating obesity development and 
glycemic deterioration [31].
Despite numerous proposed mechanisms, other studies have 
shown divergent findings on the association between snoring 
and prevalence or manifestation of type 2 diabetes mellitus. 
Several studies demonstrated that daytime sleepiness [1,9,32] 
or short sleep duration [33,34] was rather associated with al-
tered glucose metabolism, poor glycemic control, and insulin 
resistance. Perhaps, regardless of sleep phenotype, considering 
the high prevalence of snoring in the elderly population, OSA 
symptoms may be benign part of the typical aging process 
without reflecting a specific glycemic or metabolic pathology. 
In endocrinological context, sex-specific steroid hormones and 
dimorphism may support female-specific associations report-
ed in previous research [35,36]. Varied data collection tools 
and variable treatment also contribute to discrepancies in ef-
fect size. Foremost, the presence of obesity and hypertension 
yield synergistic effect on diabetes. The amalgamation of adi-
posity and sleep breathing disturbances embodies high-risk for 
type 2 diabetes mellitus and CVD [37]. Therefore, considering 
the high likelihood that adjustments may still leave residual 
confounding, we performed subgroup analyses, in which we 
confirmed that the association persisted even in non-obese 
and normotensive groups.
Strengths of the present study include meticulous break-
down of snoring and comparison of associations between its 
individual dimension with prediabetes and type 2 diabetes 
mellitus risk. Moreover, the infrastructure of this large, general 
population cohort study adeptly served in ascertaining both 
the exposure and outcome variables in standardized manners. 
Finally, the nature of healthy community-based cohort allows 
to generalize our findings in detecting high-risk group for pre-
diabetes/type 2 diabetes mellitus in ubiquitous clinic settings.
Several limitations merit consideration when interpreting 
our findings. Due to the cross-sectional study design, we were 
unable to infer specific directionality of the association between 
snoring and type 2 diabetes mellitus. Assessment of snoring 
and other sleep variables might have resulted in non-differen-
tial misclassification bias, due to differing recall capability and 
awareness of own sleep habits by the presence of bed partners. 
While subjective, use of sleep questionnaires still have fair clin-
ical applicability for its low cost and time efficiency. Moreover, 
previous studies have reported that self-reported snoring cor-
relates well with objective measures, especially among frequent 
snorers [38]. Availability of diverse sleep collection methodol-
ogy warrants further studies, in which self-reported sleep mea-
sures be replaced with wearable actigraphy or selectively re-
cruit high-risk individuals to undergo polysomnography to 
confirm reliability of sleep questionnaires. Furthermore, prior 
studies have shown that individuals who are unmarried or 
without bed partners tend to underreport their snoring [39]. 
Restricting the participants to those with bed partners may in-
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crease the accuracy of sleep measurements.
In summary, increasing snoring frequency and intensity 
were independently associated with risk of both prediabetes 
and type 2 diabetes mellitus in middle-aged adults. The associ-
ations persisted after adjustment for and stratification by obe-
sity, hypertension, and other sleep variables. Snoring may im-
pair glucose metabolism even in otherwise metabolically 
health adults; in the light of these findings, screening for type 2 
diabetes mellitus may be warranted in asymptomatic individu-
als with habitual snoring. Furthermore, snoring may be a risk 
factor for poor glycemic control in diabetes, thereby warrants 
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